GB201614037D0 - Pharmaceutical compounds - Google Patents

Pharmaceutical compounds

Info

Publication number
GB201614037D0
GB201614037D0 GBGB1614037.8A GB201614037A GB201614037D0 GB 201614037 D0 GB201614037 D0 GB 201614037D0 GB 201614037 A GB201614037 A GB 201614037A GB 201614037 D0 GB201614037 D0 GB 201614037D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compounds
pharmaceutical
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1614037.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sentinel Oncology Ltd
Original Assignee
Sentinel Oncology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sentinel Oncology Ltd filed Critical Sentinel Oncology Ltd
Priority to GBGB1614037.8A priority Critical patent/GB201614037D0/en
Publication of GB201614037D0 publication Critical patent/GB201614037D0/en
Priority to MX2018003887A priority patent/MX2018003887A/en
Priority to PCT/EP2016/073489 priority patent/WO2017055592A1/en
Priority to EP21164670.8A priority patent/EP3868751B1/en
Priority to AU2016329513A priority patent/AU2016329513B2/en
Priority to CN201680070399.8A priority patent/CN108473472B/en
Priority to EP16778295.2A priority patent/EP3356348B1/en
Priority to CA3000565A priority patent/CA3000565C/en
Priority to JP2018516710A priority patent/JP6821670B2/en
Priority to BR112018006498-0A priority patent/BR112018006498B1/en
Priority to KR1020187012246A priority patent/KR20180061318A/en
Priority to US15/764,960 priority patent/US10344033B2/en
Priority to RU2018110884A priority patent/RU2736123C1/en
Priority to IL258438A priority patent/IL258438B/en
Priority to CL2018000839A priority patent/CL2018000839A1/en
Priority to SA518391258A priority patent/SA518391258B1/en
Priority to US16/442,071 priority patent/US10730882B2/en
Ceased legal-status Critical Current

Links

GBGB1614037.8A 2015-10-02 2016-08-16 Pharmaceutical compounds Ceased GB201614037D0 (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
GBGB1614037.8A GB201614037D0 (en) 2016-08-16 2016-08-16 Pharmaceutical compounds
RU2018110884A RU2736123C1 (en) 2015-10-02 2016-09-30 2-aminoquinazoline derivatives as p70s6 kinase inhibitors
JP2018516710A JP6821670B2 (en) 2015-10-02 2016-09-30 Pharmaceutical compounds
KR1020187012246A KR20180061318A (en) 2015-10-02 2016-09-30 2-aminoquinazoline derivatives as P70S6 kinase inhibitors
EP21164670.8A EP3868751B1 (en) 2015-10-02 2016-09-30 2-aminoquinazoline derivatives as p70s6 kinase inhibitors
AU2016329513A AU2016329513B2 (en) 2015-10-02 2016-09-30 2-Aminoquinazoline derivatives as p70S6 kinase inhibitors
CN201680070399.8A CN108473472B (en) 2015-10-02 2016-09-30 2-aminoquinazoline derivatives as P70S6kinase inhibitors
EP16778295.2A EP3356348B1 (en) 2015-10-02 2016-09-30 2-aminoquinazoline derivatives as p70s6 kinase inhibitors
CA3000565A CA3000565C (en) 2015-10-02 2016-09-30 2-aminoquinazoline derivatives as p70s6 kinase inhibitors
MX2018003887A MX2018003887A (en) 2015-10-02 2016-09-30 2-aminoquinazoline derivatives as p70s6 kinase inhibitors.
BR112018006498-0A BR112018006498B1 (en) 2015-10-02 2016-09-30 COMPOUND, USE OF THE SAME AND PHARMACEUTICAL COMPOSITION
PCT/EP2016/073489 WO2017055592A1 (en) 2015-10-02 2016-09-30 2-aminoquinazoline derivatives as p70s6 kinase inhibitors
US15/764,960 US10344033B2 (en) 2015-10-02 2016-09-30 2-aminoquinazoline derivatives as P70S6 kinase inhibitors
IL258438A IL258438B (en) 2015-10-02 2018-03-28 2-aminoquinazoline derivatives as p70s6 kinase inhibitors
CL2018000839A CL2018000839A1 (en) 2015-10-02 2018-03-29 2-aminoquinazoline derivatives as p70s6 kinase inhibitors
SA518391258A SA518391258B1 (en) 2015-10-02 2018-04-01 2-aminoquinazoline derivatives as p70s6 kinase inhibitors
US16/442,071 US10730882B2 (en) 2015-10-02 2019-06-14 2-aminoquinazoline derivatives as P70S6 kinase inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1614037.8A GB201614037D0 (en) 2016-08-16 2016-08-16 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
GB201614037D0 true GB201614037D0 (en) 2016-09-28

Family

ID=56985939

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1614037.8A Ceased GB201614037D0 (en) 2015-10-02 2016-08-16 Pharmaceutical compounds

Country Status (1)

Country Link
GB (1) GB201614037D0 (en)

Similar Documents

Publication Publication Date Title
IL266017A (en) Pharmaceutical compounds
GB201612092D0 (en) Pharmaceutical compounds
IL258213B (en) Pharmaceutical compounds
GB201617758D0 (en) Pharmaceutical compounds
GB201506658D0 (en) Pharmaceutical compounds
IL258246A (en) Pharmaceutical compounds
GB201504675D0 (en) Pharmaceutical compounds
GB201506660D0 (en) Pharmaceutical compounds
ZA201900540B (en) Pharmaceutical compounds
GB201519352D0 (en) Pharmaceutical compounds
HUE052107T2 (en) Pharmaceutical compounds
GB201709652D0 (en) Pharmaceutical compounds
GB201612095D0 (en) Pharmaceutical compounds
GB201617454D0 (en) Pharmaceutical compounds
GB201704965D0 (en) Pharmaceutical compounds
GB201704714D0 (en) Pharmaceutical compounds
GB201703881D0 (en) Pharmaceutical compounds
GB201506933D0 (en) Pharmaceutical compounds
GB201502567D0 (en) Pharmaceutical compounds
GB201706806D0 (en) Pharmaceutical compounds
GB201704966D0 (en) Pharmaceutical compounds
GB201617871D0 (en) Pharmaceutical compounds
ZA201904033B (en) Pharmaceutical compounds
GB201615912D0 (en) Pharmaceutical compound
GB201615916D0 (en) Pharmaceutical compound

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)